Zhanqiang Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhanqiang Ma has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Mingyan Wang
Discipline of Chinese and Western Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210046, China
1 shared publication- Qiang Fu
Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 210009, PR China
1 shared publication Rong Qu
Discipline of Chinese and Western Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210046, China
1 shared publication- Shiping Ma
Department of Pharmacology of Chinese Materia Medica China Pharmaceutical University Nanjing China
1 shared publication Weiwei Ji
Department of Pharmacology for Chinese Materia Medica, China Pharmaceutical University, Nanjing, Jiangsu 211198, China
1 shared publicationWen Yang
Department of Pharmacology for Chinese Materia Medica, China Pharmaceutical University, Nanjing, Jiangsu 211198, China
1 shared publication
Latest Publications
- Open Access
- 23 October 2013
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2013, 1-9
Metabonomic Study on the Antidepressant-Like Effects of Banxia Houpu Decoction and Its Action Mechanism
The aim of this study was to establish an experimental model for metabonomic profiles of the rat’s brain and then to investigate the antidepressant effect of Banxia Houpu decoction (BHD) and its possible mechanisms. Behavioral research and metabonomics method based on UPLC-MS were used to assess the efficacy of different fractions of BHD on chronic unpredictable mild stress (CUMS) model of depression. There was a significant difference between the BHD group and the model group. Eight endogenous metabolites, which are contributing to the separation of the model group and control group, were detected, while BHD group regulated the perturbed metabolites showing that there is a tendency of recovery compared to control group. Therefore, we think that those potential metabolite biomarkers have some relationship with BHD’s antidepression effect. This work appraised the antidepressant effect of Banxia Houpu decoction as well as revealing a metabonomics method, a valuable parameter in the TCM research.
- 23 October 2013
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2013, 1-9
Open AccessMetabonomic Study on the Antidepressant-Like Effects of Banxia Houpu Decoction and Its Action Mechanism
The aim of this study was to establish an experimental model for metabonomic profiles of the rat’s brain and then to investigate the antidepressant effect of Banxia Houpu decoction (BHD) and its possible mechanisms. Behavioral research and metabonomics method based on UPLC-MS were used to assess the efficacy of different fractions of BHD on chronic unpredictable mild stress (CUMS) model of depression. There was a significant difference between the BHD group and the model group. Eight endogenous metabolites, which are contributing to the separation of the model group and control group, were detected, while BHD group regulated the perturbed metabolites showing that there is a tendency of recovery compared to control group. Therefore, we think that those potential metabolite biomarkers have some relationship with BHD’s antidepression effect. This work appraised the antidepressant effect of Banxia Houpu decoction as well as revealing a metabonomics method, a valuable parameter in the TCM research.